Skip to content

Omnicell OMCL Return on equity

Return on equity at other companies

Baxter International logo
Baxter InternationalBAX
-16.7%-76.7pp
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
4.6%-1.3pp
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
16.9%
Guardian Pharmacy Services logo
Guardian Pharmacy ServicesGRDN
26.8%
Cencora logo
CencoraCOR
130.6%-99.8pp
ICU Medical logo
ICU MedicalICUI
-0.4%-0.2pp

Other financials

Income statement

See full
Revenue$309.9M+14.9%
Gross profit$140.4M+26.5%
Operating income$16.9M+245%
Net income$11.4M+262%
EPS (diluted)$0.25+267%

Balance sheet

See full
Cash & equivalents$291.0M-29.8%
Total debt$34.3M-23.1%
Total equity$1.3B0.0%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$54.5M+110%
CapEx$12.4M+11.3%
Free cash flow$42.1M+185%

Valuation

See full
Market cap$1.75B-7.2%
Enterprise value$1.49B-0.4%
P/E113.2×
P/S1.4×-0.2×

Profitability

See full
Gross margin43.5%+0.4pp
Operating margin2.7%+1.8pp
Net margin1.7%+1.1pp
FCF margin9.3%-1.7pp

Returns & leverage

See full
Debt / equity0.0×
Current ratio1.5×+0.1×

Where this comes from

Calculated from Omnicell’s reported figures.

Based on trailing twelve months.

The official record: Omnicell’s 10-Q, filed November 5, 2025, on SEC EDGAR. View the filing →

Ask your AI about Omnicell's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Omnicell's return on equity?
Omnicell (OMCL) reported return on equity of 1.6% in Q3 2025.
How has Omnicell's return on equity changed year-over-year?
Omnicell's return on equity increased by 211.1% year-over-year, from -1.5% to 1.6%.
What is the long-term trend for Omnicell's return on equity?
Over 3 years (2020 to 2024), Omnicell's return on equity has grown at a -33.8% compound annual growth rate (CAGR), from 3.6% to 1%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.